Cargando…
Vibrio cholera Bacteremia Secondary to Ascending Cholangitis in a Patient Not on Chemotherapy or Immunosuppressants
Non-O1, non-O139 Vibrio cholera (NOVC) are considered non-pathogenic organisms, but in some cases, it is known to be responsible for self-limiting intestinal and extra-intestinal infections in immunocompetent individuals. On the other hand, NOVC bacteremia affects mainly immunocompromised patients w...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8712209/ https://www.ncbi.nlm.nih.gov/pubmed/34976485 http://dx.doi.org/10.7759/cureus.19853 |
_version_ | 1784623518098391040 |
---|---|
author | Bogari, Anas A Alsolami, Basel M Al-Husayni, Faisal Munshi, Adeeb Alharbi, Maher |
author_facet | Bogari, Anas A Alsolami, Basel M Al-Husayni, Faisal Munshi, Adeeb Alharbi, Maher |
author_sort | Bogari, Anas A |
collection | PubMed |
description | Non-O1, non-O139 Vibrio cholera (NOVC) are considered non-pathogenic organisms, but in some cases, it is known to be responsible for self-limiting intestinal and extra-intestinal infections in immunocompetent individuals. On the other hand, NOVC bacteremia affects mainly immunocompromised patients with significantly high mortality rates. We report a case of an 80-year-old female with a 20-year history of multiple abdominal surgeries. She is also known to have ischemic heart disease and atrial fibrillation. The patient presented with abdominal pain and signs of septic shock. Her abdominal imaging showed features of ascending cholangitis, while her blood culture grew V. cholera. She was discharged after completing the course of antibiotics but then came back with a similar presentation. The repeated blood culture showed Clostridium perfringens, while other cultures were negative. The patient's condition worsened due to sepsis, and she passed away. NOVC bacteremia is a fatal disease even in hosts who are not receiving immunosuppressants or chemotherapy. It may present without a history of diarrhea or seafood ingestion. In such situations, abdominal imaging is necessary to identify the presence of intra-abdominal infections. |
format | Online Article Text |
id | pubmed-8712209 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Cureus |
record_format | MEDLINE/PubMed |
spelling | pubmed-87122092021-12-30 Vibrio cholera Bacteremia Secondary to Ascending Cholangitis in a Patient Not on Chemotherapy or Immunosuppressants Bogari, Anas A Alsolami, Basel M Al-Husayni, Faisal Munshi, Adeeb Alharbi, Maher Cureus Internal Medicine Non-O1, non-O139 Vibrio cholera (NOVC) are considered non-pathogenic organisms, but in some cases, it is known to be responsible for self-limiting intestinal and extra-intestinal infections in immunocompetent individuals. On the other hand, NOVC bacteremia affects mainly immunocompromised patients with significantly high mortality rates. We report a case of an 80-year-old female with a 20-year history of multiple abdominal surgeries. She is also known to have ischemic heart disease and atrial fibrillation. The patient presented with abdominal pain and signs of septic shock. Her abdominal imaging showed features of ascending cholangitis, while her blood culture grew V. cholera. She was discharged after completing the course of antibiotics but then came back with a similar presentation. The repeated blood culture showed Clostridium perfringens, while other cultures were negative. The patient's condition worsened due to sepsis, and she passed away. NOVC bacteremia is a fatal disease even in hosts who are not receiving immunosuppressants or chemotherapy. It may present without a history of diarrhea or seafood ingestion. In such situations, abdominal imaging is necessary to identify the presence of intra-abdominal infections. Cureus 2021-11-24 /pmc/articles/PMC8712209/ /pubmed/34976485 http://dx.doi.org/10.7759/cureus.19853 Text en Copyright © 2021, Bogari et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Internal Medicine Bogari, Anas A Alsolami, Basel M Al-Husayni, Faisal Munshi, Adeeb Alharbi, Maher Vibrio cholera Bacteremia Secondary to Ascending Cholangitis in a Patient Not on Chemotherapy or Immunosuppressants |
title | Vibrio cholera Bacteremia Secondary to Ascending Cholangitis in a Patient Not on Chemotherapy or Immunosuppressants |
title_full | Vibrio cholera Bacteremia Secondary to Ascending Cholangitis in a Patient Not on Chemotherapy or Immunosuppressants |
title_fullStr | Vibrio cholera Bacteremia Secondary to Ascending Cholangitis in a Patient Not on Chemotherapy or Immunosuppressants |
title_full_unstemmed | Vibrio cholera Bacteremia Secondary to Ascending Cholangitis in a Patient Not on Chemotherapy or Immunosuppressants |
title_short | Vibrio cholera Bacteremia Secondary to Ascending Cholangitis in a Patient Not on Chemotherapy or Immunosuppressants |
title_sort | vibrio cholera bacteremia secondary to ascending cholangitis in a patient not on chemotherapy or immunosuppressants |
topic | Internal Medicine |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8712209/ https://www.ncbi.nlm.nih.gov/pubmed/34976485 http://dx.doi.org/10.7759/cureus.19853 |
work_keys_str_mv | AT bogarianasa vibriocholerabacteremiasecondarytoascendingcholangitisinapatientnotonchemotherapyorimmunosuppressants AT alsolamibaselm vibriocholerabacteremiasecondarytoascendingcholangitisinapatientnotonchemotherapyorimmunosuppressants AT alhusaynifaisal vibriocholerabacteremiasecondarytoascendingcholangitisinapatientnotonchemotherapyorimmunosuppressants AT munshiadeeb vibriocholerabacteremiasecondarytoascendingcholangitisinapatientnotonchemotherapyorimmunosuppressants AT alharbimaher vibriocholerabacteremiasecondarytoascendingcholangitisinapatientnotonchemotherapyorimmunosuppressants |